Coronary beta-adrenoceptor function is modified by the endothelium in heart failure

Area of Science:

• Cardiovascular Physiology
• Pharmacology
• Heart Failure Research

Background:

• Congestive heart failure is linked to myocardial beta-adrenoceptor dysfunction.
• Vascular beta-adrenoceptor alterations in heart failure are not well understood.

Purpose of the Study:

• To investigate beta-adrenoceptor-mediated relaxations in coronary arteries during heart failure.
• To determine the influence of the endothelium and heart failure stage on these responses.

Main Methods:

• Induction of early (1 week) and end-stage (4 weeks) heart failure in dogs via rapid ventricular pacing.
• Assessment of beta-adrenoceptor-mediated relaxations to isoproterenol and salbutamol in circumflex (CRX) and left anterior descending (LAD) coronary arteries, with and without endothelium.

Main Results:

• Early heart failure: CRX arteries with endothelium showed increased sensitivity to isoproterenol but reduced relaxation to salbutamol compared to those without endothelium.
• End-stage heart failure: Both CRX and LAD arteries with endothelium had decreased sensitivity to isoproterenol.
• End-stage heart failure: LAD arteries with endothelium exhibited greater relaxation to salbutamol than those without; CRX arteries were more sensitive to isoproterenol than LAD arteries.

Conclusions:

• Coronary vascular tone regulation via beta-adrenoceptor stimulation is coronary artery-specific.
• The presence of a functional endothelium significantly modulates these responses.
• Heart failure state and endothelium integrity are key factors influencing beta-adrenoceptor function in coronary arteries.